Latest News and Press Releases

EXTON, PA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Hematologists across the United States are redefining what “success” looks like in hemophilia treatment, according to the latest findings from Market...

Aptose’s Tuspetinib Exceeds Expectations When Combined with Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML

CLEVELAND, Ohio, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the IMF Nurse Leadership Board (NLB) proudly inaugurated and presented the first ever NLB...

EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging...

American Oncology Network and The Center for Cancer and Blood Disorders Welcome Dr. Garrett Diltz and Dr. Shreya Desai

• Safety Review Committee endorses escalation to 160 mg TUS dosing; no dose-limiting toxicities to date

EXTON, PA, Aug. 06, 2025 (GLOBE NEWSWIRE) --  According to the latest findings from Spherix Global Insights’ syndicated Market Dynamix™ service, the US sickle cell disease (SCD) market is...

EXTON, PA, July 29, 2025 (GLOBE NEWSWIRE) -- According to new findings from Spherix Global Insights’ syndicated Market Dynamix™ service, hematologists managing patients with warm autoimmune...

EXTON, PA, July 17, 2025 (GLOBE NEWSWIRE) -- In the latest Special Topix™: Co-Management Approaches in aHUS (US), Spherix Global Insights explores the nuanced dynamics between hematologists and...

EXTON, PA, July 08, 2025 (GLOBE NEWSWIRE) -- Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, chronic blood disorder that can affect individuals of any age, race, or gender, though it is most...